Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties

被引:25
作者
Jawale, Dhanaji V. [1 ]
Pratap, Umesh R. [1 ]
Rahuja, Neha [2 ]
Srivastava, Arvind K. [2 ]
Mane, Ramrao A. [1 ]
机构
[1] Dr Babasaheb Ambedkar Marathwada Univ, Dept Chem, Aurangabad 431004, Maharashtra, India
[2] Cent Drug Res Inst, Div Biochem, Lucknow 226001, Uttar Pradesh, India
关键词
2,4-Thiazolidinedione; Sulfonylurea; Antihyperglycemic activity; Curtius rearrangement; Diabetes mellitus; HYPOGLYCEMIC AGENTS; LIPID-METABOLISM; PPAR-GAMMA; FATTY RATS; THIAZOLIDINEDIONE; GLIBENCLAMIDE; CIGLITAZONE; METFORMIN; ANALOGS; LIGAND;
D O I
10.1016/j.bmcl.2011.10.110
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New 2,4-thiazolidinediones with aryl sulfonylurea moieties 8a-h have been synthesized by condensing various substituted sulfonamides and 5-(isocyanatomethyl) thiazolidino-2,4-dione 6. The isocyanomethyl thiazolidinedione was obtained by using the Curtius rearrangement, starting from known 2,4-dioxo-5-thiazolidineacetic acid 4. The newly synthesized compounds 8a-h have been evaluated for the antihyperglycemic activity in normal rats model and among these compounds 8b, 8c, 8e and 8f showed significant antihyperglycemic activity in sucrose loaded rat model. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:436 / 439
页数:4
相关论文
共 34 条
[1]  
[Anonymous], 1996, NEW ENGL J MED
[2]  
[Anonymous], BIOORG MED CHEM LETT
[3]  
[Anonymous], TXB DIABETES
[4]  
Ashford M. L. J, 1990, POTASSIUM CHANNELS S, P300
[5]   BIGUANIDES AND NIDDM [J].
BAILEY, CJ .
DIABETES CARE, 1992, 15 (06) :755-772
[6]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[7]   THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT [J].
CANTELLO, BCC ;
CAWTHORNE, MA ;
HAIGH, D ;
HINDLEY, RM ;
SMITH, SA ;
THURLBY, PL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) :1181-1184
[8]   CIGLITAZONE, A NEW HYPOGLYCEMIC AGENT .1. STUDIES IN OB/OB AND DB/DB MICE, DIABETIC CHINESE HAMSTERS, AND NORMAL AND STREPTOZOTOCIN-DIABETIC RATS [J].
CHANG, AY ;
WYSE, BM ;
GILCHRIST, BJ ;
PETERSON, T ;
DIANI, AR .
DIABETES, 1983, 32 (09) :830-838
[9]   SUBSTITUTED DIHYDROBENZOPYRAN AND DIHYDROBENZOFURAN THIAZOLIDINE-2,4-DIONES AS HYPOGLYCEMIC AGENTS [J].
CLARK, DA ;
GOLDSTEIN, SW ;
VOLKMANN, RA ;
EGGLER, JF ;
HOLLAND, GF ;
HULIN, B ;
STEVENSON, RW ;
KREUTTER, DK ;
GIBBS, EM ;
KRUPP, MN ;
MERRIGAN, P ;
KELBAUGH, PL ;
ANDREWS, EG ;
TICKNER, DL ;
SULESKE, RT ;
LAMPHERE, CH ;
RAJECKAS, FJ ;
KAPPELER, WH ;
MCDERMOTT, RE ;
HUTSON, NJ ;
JOHNSON, MR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) :319-325
[10]   Recent developments in the biology and medicinal chemistry of potassium channel modulators: Update from a decade of progress [J].
Coghlan, MJ ;
Carroll, WA ;
Gopalakrishnan, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) :1627-1653